Researchers show that study participants can be safely, effectively monitored at home for drugs’ potential arrhythmic effects.
Researchers are still enrolling study participants who have not already received a vaccine booster against SARS-CoV-2.
UW Medicine was one of the clinical trial sites for aducanumab, a drug approved yesterday by the Food and Drug Administration to slow the progression of Alzheimer’s disease in people with mild symptoms.
Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.
Results in Open Forum Infectious Diseases show hydroxychloroquine does not protect people from the novel coronavirus.
In a large U.S. trial, more than 70% of patients randomized to receive antibiotics ultimately avoided surgery, investigators found.
Veana and UW Medicine are evaluating a combination of alpha-TEA and trastuzumab for advanced HER2 positive breast cancer
In a therapeutic study, outcomes of 35 patients compared favorably with historical data of those treated with standard chemo and radiation therapy.
In April, Ed Ward, 74, became the first patient on the West Coast to receive a test device implanted in his heart to reduce the symptoms of heart failure. Dr.
Appliance is designed to cinch the mitral valve so it closes fully, preventing backflow of blood that adds to heart-failure patients' fatigue.